The first genetically engineered pigs for use as food or for potential future biomedical use—such as transplantation—in humans have been approved by the U.S. Food and Drug Administration.

These GalSafe pigs were created to eliminate on the surface of the pigs’ cells. People with Alpha-gal syndrome (AGS) may have mild-to-severe allergic reactions to alpha-gal sugar found in red meat such as pork, beef, and lamb. In the United States. AGS most often begins when a Lone Star tick bites someone and transmits alpha-gal sugar into the person’s body, causing an immune system reaction in some that later produces mild-to-severe allergic reactions to alpha-gal sugar found in red meat.

The product developer, Revivicor Inc., indicated that it initially intends to sell meat from GalSafe pigs by mail order, rather than in supermarkets, according to the FDA.

“Today’s first ever approval of an animal biotechnology product for both food and as a potential source for biomedical use represents a tremendous milestone for scientific innovation,” FDA Commissioner Stephen Hahn, M.D., said in an agency news release.

The have not been evaluated by the FDA as sources of medical products for transplantation or implantation into people. Developers of such products would first have to obtain approval from the FDA before these products can be used in , the agency said.

Likelihood of tick bite to cause red meat allergy could be higher than previously thought

More information:
More Information

Copyright © 2020 HealthDay. All rights reserved.

FDA approves genetically engineered pigs for food, possible medical use (2020, December 15)
retrieved 15 December 2020

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Source link